More answers like this
GPT-5Sep 9, 2026openai/gpt-5-2025-08-07
Should AI development be paused or restricted?
Short answer: Don’t pause AI development across the board. Do impose risk‑proportionate restrictions and be willing to pause specific high‑risk training or deployments until safety requirements are met.
Why some call for a pause
•Frontier risks: models that could enable large‑scale cyberattacks, design dangerous biological agents, evade oversight, or autonomously pursue goals.
•Deployment outpacing governance: weak standards, limited auditing, and unclear liability.
•Externalities: misinformation, labor shocks, privacy harms, and concentration of power.
Why a blanket pause is a bad idea
•Foregoes major benefits (healthcare, accessibility, education, climate, productivity).
•Entrenches incumbents and shifts work to unregulated jurisdictions.
•Pausing everything doesn’t target the small subset of models and use‑cases that create outsized risk.
What to restrict (capabilities-based, not just size/parameters)
•Biohazard assistance: step‑by‑step protocols, pathogen design, or wet‑lab orchestration.
•Offensive cyber capability: exploit discovery, weaponized automation, scalable phishing/persuasion.
•Deception and autonomy: tool‑using agents that can conceal actions, replicate, or move money.
•Critical-infrastructure control and high-stakes domains (medical diagnosis, autonomous vehicles).
•Election integrity and targeted persuasion.
How to do it (tiered, risk‑proportionate governance)
1)Low risk (narrow, well‑bounded apps): No pause. Follow security, privacy, and bias best practices.
2)Medium risk (general-purpose models without dangerous capabilities):
•Pre‑deployment model evaluations, misuse red‑teaming, and safety disclosures.
•Content provenance and synthetic media labeling; abuse monitoring and rate limits.
•Transparent data and fine‑tuning sources where feasible; user privacy protections.
3)High risk (frontier or agentic models with plausible dangerous capabilities):
•Licensing before training above regulator‑set compute/capability thresholds.
•Pre‑training notification to regulators and secure compute requirements.
•Independent third‑party evaluations for bio/cyber/deception/autonomy; publish a safety case.
•Secure development: model and weight security, insider‑threat controls, incident reporting.
•Restricted release: staged or gated access; avoid open‑weight release until risks are demonstrably manageable.
•Deployment guardrails: tool/use whitelists, spending and API caps, identity‑verified access for sensitive tools, continuous monitoring, and kill‑switches.
4)Extreme risk (models exhibiting uncontrolled autonomy or catastrophic capability indicators):
•Time‑bound pause on training and/or deployment until safety benchmarks are passed, with regulator oversight.
Concrete policy tools governments can use
•Compute governance: reporting for large training runs; secure hardware with attestation; cloud logging; export controls for the most advanced accelerators.
•Model evaluations: standardized red‑team protocols for bio/cyber and deception; external audits; post‑deployment monitoring.
•Safety and security standards: adopt/mandate frameworks (e.g., NIST AI RMF, ISO/IEC AI risk management), secure-by-design guidance, and incident reporting.
•Liability and duty of care: clearer responsibility for foreseeable misuse in high‑risk deployments.
•Content authenticity: provenance standards (e.g., C2PA) and watermarks for synthetic media, especially around elections.
•International coordination: align thresholds, share eval methods, and coordinate on chip/export and incident response.
Guidance for different actors
•Labs: commit to responsible scaling policies; publish safety cases; invest in interpretability, red‑teaming, and model security; stage releases.
•Companies using AI: run domain‑specific risk assessments; keep humans-in-the-loop for high‑stakes decisions; log and audit model use.
•Open‑source community: favor “responsible release” (delayed or gated) for strong general‑purpose or agentic models; freely share safety tools, evals, and narrow models that don’t raise catastrophic risk.
•Researchers and funders: prioritize safety, robustness, and evaluations; support shared testbeds and compute for safety science.
Bottom line
•No blanket pause. Keep advancing beneficial AI.
•Enforceable restrictions and oversight for high‑risk capabilities.
•Be prepared to pause specific training or deployment when independent evaluations show unacceptable risk or absent safety cases.
This balances innovation with meaningful protection against real harms and tail risks.